His scientific interests lie mostly in Mycosis fungoides, Lymphoma, Pathology, Cutaneous T-cell lymphoma and Peripheral T-cell lymphoma. His Mycosis fungoides research incorporates themes from Southern blot, Blot, Skin biopsy, T-cell receptor and Stage. His Lymphoma study incorporates themes from Cancer research, Karyotype, Chromosomal translocation, Dermatology and Loss of heterozygosity.
The various areas that Sean Whittaker examines in his Dermatology study include Cancer, Primary cutaneous marginal zone lymphoma, Clinical trial and Primary cutaneous anaplastic large cell lymphoma. Pathology and Immunophenotyping are commonly linked in his work. While the research belongs to areas of Cutaneous T-cell lymphoma, Sean Whittaker spends his time largely on the problem of Refractory, intersecting his research to questions surrounding Zanolimumab.
Sean Whittaker mostly deals with Mycosis fungoides, Pathology, Lymphoma, Cutaneous T-cell lymphoma and Internal medicine. His studies deal with areas such as Dermatology, Clinical trial, Peripheral T-cell lymphoma and Stage as well as Mycosis fungoides. His Immunophenotyping research extends to Pathology, which is thematically connected.
As part of one scientific family, he deals mainly with the area of Lymphoma, narrowing it down to issues related to the Molecular biology, and often Comparative genomic hybridization and Chromosome. His research in Cutaneous T-cell lymphoma intersects with topics in Cancer research, Gene and Phases of clinical research. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology.
His scientific interests lie mostly in Internal medicine, Mycosis fungoides, Cutaneous T-cell lymphoma, Oncology and Cancer research. The Brentuximab vedotin, Quality of life, Methotrexate and Clinical trial research Sean Whittaker does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Bexarotene, therefore creating a link between diverse domains of science. His Mycosis fungoides research includes themes of Dermatology and Surgery.
When carried out as part of a general Dermatology research project, his work on Skin pathology is frequently linked to work in Index, therefore connecting diverse disciplines of study. His biological study spans a wide range of topics, including Previously treated and Young adult. His Oncology research incorporates elements of Retrospective cohort study and Gemcitabine, Chemotherapy.
His primary scientific interests are in Mycosis fungoides, Internal medicine, Cutaneous T-cell lymphoma, Lymphoma and Pathology. The concepts of his Mycosis fungoides study are interwoven with issues in T-cell lymphoma and Surgery. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
His research integrates issues of Palliative care, Clinical endpoint, Disease and Gerontology in his study of Cutaneous T-cell lymphoma. His work in Lymphoma covers topics such as Phases of clinical research which are related to areas like Folliculotropic Mycosis Fungoides and Young adult. His work in the fields of Pathology, such as Cutaneous lymphoma and Differential diagnosis, overlaps with other areas such as Peripheral blood mononuclear cell.
WHO-EORTC classification for cutaneous lymphomas.
Rein Willemze;Elaine S. Jaffe;Günter Burg;Lorenzo Cerroni.
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).
Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze.
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Sally Agar;Emma Wedgeworth;Siobhan Crichton;Tracey J. Mitchell.
Journal of Clinical Oncology (2010)
Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook.
Journal of Clinical Oncology (2010)
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.
Rein Willemze;Patty M. Jansen;Lorenzo Cerroni;Emilio Berti.
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic.
Journal of Clinical Oncology (2011)
Defining early mycosis fungoides.
Nicola Pimpinelli;Elise A. Olsen;Marco Santucci;Eric Vonderheid.
Journal of The American Academy of Dermatology (2005)
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Youn H. Kim;Rein Willemze;Nicola Pimpinelli;Sean Whittaker.
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot.
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Franz Trautinger;Robert Knobler;Rein Willemze;Ketty Peris.
European Journal of Cancer (2006)
If you think any of the details on this page are incorrect, let us know.